A closer look at Doleac and Mukherjee (2022) and the effects of naloxone access laws on opioid ER admissions.
In their 2022 study, 'The Effects of Naloxone Access Laws on Opioid Abuse, Mortality, and Crime,' Doleac and Mukherjee conclude that broadening access to a life‐saving drug—naloxone—does not reduce opioid‐related mortality as the drug simultaneously encourages riskier drug use. I show issues with th...
| Publicado en: | Economic Inquiry Vol. 64; no. 1; pp. 54 - 88 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Wiley-Blackwell
Jan2026
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=190789046&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 190789046 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00952583 EIQ jtl: Economic Inquiry issn: 00952583 maglogo: Y pubinfo: dt: Jan2026 vid: 64 iid: 1 pid: 480 pub: Wiley-Blackwell artinfo: ui: 190789046 10.1111/ecin.13277 ppf: 54 ppct: 34 formats: fmt: – @attributes: type: T – @attributes: type: C – @attributes: type: P size: 10.7MB tig: atl: A closer look at Doleac and Mukherjee (2022) and the effects of naloxone access laws on opioid ER admissions. aug: au: Alexeev, Sergey affil: NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown New South Wales, , Australia su: Epidemiology Emergency room visits Pharmaceutical policy Drug addict mortality Research methodology Opioid epidemic sug: subj: Epidemiology Pharmaceuticals and pharmacy supplies merchant wholesalers Pharmaceutical and medicine manufacturing Drugs and Druggists' Sundries Merchant Wholesalers Emergency room visits Pharmaceutical policy Drug addict mortality Research methodology Opioid epidemic keyword: harm reduction health economics naloxone access laws opioid crisis overdose prevention public health policy reproducibility harm reduction health economics naloxone access laws opioid crisis overdose prevention public health policy reproducibility ab: In their 2022 study, 'The Effects of Naloxone Access Laws on Opioid Abuse, Mortality, and Crime,' Doleac and Mukherjee conclude that broadening access to a life‐saving drug—naloxone—does not reduce opioid‐related mortality as the drug simultaneously encourages riskier drug use. I show issues with their data, design, and estimation methods. For example, their Google Search data has an unverifiable origin, the law timing is incorrect, and the statistical inference is invalid. Correcting these issues within a triple difference design shows that naloxone, contrary to their findings, does not increase ER opioid admissions. I conclude that the moral hazard (and the ensuing adverse consequences) of naloxone use lacks empirical support. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|